Abstract:Objectives: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in China and, due to the limited efficacy of currently available therapies, is responsible for a large number of deaths. IFN-alpha therapy has shown promise in the treatment of various forms of human cancer and is considered in the treatment of HCC. Previous results from our group showed that high doses of IFN-alpha exert a significant antiproliferative effect on MHCC97 human xenografts in nude mice, but not on MHCC97 cells when tested in vitro. Here we present experiments designed to characterize the molecular mechanism underlying the defective response of MHCC97 cells to IFN-alpha. Elucidation of the mechanism underlying the defective response of MHCC97 to IFN-alpha may help to explain and possibly to overcome clinical failures of this form of tumor therapy. Methods: IFN-alpha(2a) was administered between 3,000 and 10,000 IU/ml, a range strongly inhibiting proliferation in other cell lines. Gene expression profiles of MHCC97 cells were obtained before and after treatment with IFN-alpha(2a) using cDNA microarray analysis. The transcriptional activity of relevant genes responding to IFN-alpha(2a) in the cDNA microarray experiments was confirmed by RT-PCR and Northern blot analysis. Transient transfection with an expression vector was used to restore p48-ISGFA (IRF9) protein levels. Cell proliferation was evaluated using the MTT assay. Results: Although IFN-alpha treatment caused the activation of several signal transduction pathways in MHCC97 cells, the lack of an antiproliferative effect was found to mainly derive from a defect in the activation of the transcription factor ISGF3 required for Jak/STATS signaling. We show that the defect in ISGF3 activation is mainly caused by the absence of one of its essential components, the protein p48-ISGFgamma from MHCC97 cells. Indeed, transient expression of p48-ISGFgamma restores sensitivity to IFN-alpha(2a). Although the mRNA levels of p48-ISGFgamma were normal in MHCC97 cells, mutations could be detected in the gene coding for the protein. We hypothesize, therefore, that these mutations alter the message or protein stability, leading to the reduced protein levels observed. Conclusion: Our results confirm the important role of Jak/STATS signaling in the antiproliferative effects of IFN-alpha in tumor cells and indicate that defects in ISGF3 can cause resistance to IFN-alpha(2a) treatment. Copyright (C) 2004 S. Karger AG, Basel.

Reconstructing the JAK/STATs Signal Pathway Restored the Anti-Proliferative Response of MHCC97 on Interferon Alpha

The Expression of Several Molecules in JAK/STATs Signaling Pathway in MHCC97 Hepatocellular Carcinoma Cells with High Metastatic Potential

Reduction in P48-Isgfgamma Levels Confers Resistance to Interferon-Alpha2a in MHCC97 Cells.

Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α<sub>2a</sub> in MHCC97 Cells

Ifr-9/Stat2 Functional Interaction Drives Retinoic Acid-Induced Gene G Expression Independently Of Stat1

[Effect of Homoharringtonine Combined with AG490 on JAK2-STAT5 Associated Signal Pathway in HEL Cells].

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

Modulation of Gene Expression in MHCC97 Cells by Interferon Alpha

Hyper-activated IRF-1 and STAT1 contribute to enhanced interferon stimulated gene (ISG) expression by interferon alpha and gamma co-treatment in human hepatoma cells.

Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis.

Hyper-activated IRF-1 and STAT1 contribute to enhanced Interferon stimulated gene (ISG) expression by Interferon α and γ co-treatment in human hepatoma cells

The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.

Interferon induced transmembrane protein 1 with interferon α synergistically inhibited proliferation of colorectal cancer cell line SW480

A deficient MIF-CD74 signaling pathway may play an important role in immunotherapy-induced hyper-progressive disease

The Importance of Stat6 Regulated Genes Activated by Type I Interferon

Elevated type I interferon signaling defines the proliferative advantage of ARF and p53 mutant tumor cells

Opposing Effects of Interferon-Alpha and Interferon-Gamma on the Expression of Major Histocompatibility Complex Class I Chain-Related A in Tumors.

Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia

ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV]